Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OX0V
|
|||
| Former ID |
DNC005883
|
|||
| Drug Name |
2-(4-ethylthiobenzimidazol-2-yl)quinoxaline
|
|||
| Synonyms |
CHEMBL198008; benzimidazole-quinoxaline, C2; BDBM21216; 2-[4-(ethylsulfanyl)-1H-benzimidazol-2-yl]quinoxaline
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H14N4S
|
|||
| Canonical SMILES |
CCSC1=CC=CC2=C1N=C(N2)C3=NC4=CC=CC=C4N=C3
|
|||
| InChI |
1S/C17H14N4S/c1-2-22-15-9-5-8-13-16(15)21-17(20-13)14-10-18-11-6-3-4-7-12(11)19-14/h3-10H,2H2,1H3,(H,20,21)
|
|||
| InChIKey |
IHVQPVYBIZVMSJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database search... J Med Chem. 2005 Dec 29;48(26):8253-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.